Val J Watts Selected Research

Ethanol (Ethyl Alcohol)

1/2021	The CUL3/neddylation inhibitor MLN4924 reduces ethanol-induced locomotor sensitization and inflammatory pain allodynia in mice.
1/2018	Identification of FDA-Approved Small Molecules Capable of Disrupting the Calmodulin-Adenylyl Cyclase 8 Interaction through Direct Binding to Calmodulin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Val J Watts Research Topics

Disease

6	Pain (Aches) 01/2022 - 02/2015
5	Chronic Pain 01/2022 - 01/2018
4	Yellow Fever 03/2015 - 01/2012
3	Whooping Cough (Pertussis) 01/2018 - 08/2015
3	Parkinson Disease (Parkinson's Disease) 03/2015 - 07/2012
2	Hyperalgesia 01/2022 - 01/2021
2	Anthrax 01/2018 - 11/2016
2	Schizophrenia (Dementia Praecox) 03/2015 - 01/2015
2	Lyme Disease (Disease, Lyme) 11/2012 - 08/2011
2	Central Nervous System Diseases (CNS Diseases) 01/2012 - 04/2007
1	Dyskinesias (Dyskinesia) 04/2024
1	Neoplasms (Cancer) 03/2024
1	Hypersensitivity (Allergy) 01/2022
1	Toxemia 01/2018
1	Filarial Elephantiasis (Lymphatic Filariasis) 03/2015
1	Neglected Diseases 03/2015
1	Substance-Related Disorders (Drug Abuse) 01/2014
1	Nervous System Diseases (Neurological Disorders) 01/2014
1	Vector Borne Diseases 01/2012
1	Animal Diseases 08/2011
1	Body Weight (Weight, Body) 09/2006
1	Neuroblastoma 01/2004
1	Mental Disorders (Mental Disorder) 10/2003

Drug/Important Bio-Agent (IBA)

10	Adenylyl Cyclases (Adenylyl Cyclase)IBA 04/2024 - 01/2004
7	Dopamine Receptors (Dopamine Receptor)IBA 03/2015 - 01/2004
3	adenylyl cyclase 1IBA 01/2022 - 01/2022
3	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2018
2	Protein Isoforms (Isoforms)IBA 03/2024 - 04/2007
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2022 - 01/2019
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2018
2	Adenylate Cyclase ToxinIBA 01/2018 - 11/2016
2	Virulence Factors (Pathogenicity Factors)IBA 01/2018 - 11/2016
2	edema factorIBA 01/2018 - 11/2016
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 03/2015 - 01/2015
2	Antipsychotic Agents (Antipsychotics)IBA 01/2015 - 01/2015
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015 - 08/2011
2	Dopamine AntagonistsIBA 11/2012 - 01/2012
2	Dopamine (Intropin)FDA LinkGeneric 11/2012 - 07/2012
2	Neurotransmitter Agents (Neurotransmitter)IBA 08/2011 - 10/2003
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	Freund's AdjuvantIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	PyrimidinonesIBA 01/2022
1	Cocaine (Cocaine HCl)IBA 01/2021
1	pevonedistatIBA 01/2021
1	1,3,4-oxadiazoleIBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	Organophosphonates (Phosphonates)IBA 08/2015
1	NucleosidesIBA 08/2015
1	PesticidesIBA 03/2015
1	InsecticidesIBA 03/2015
1	Adenylyl Cyclase InhibitorsIBA 02/2015
1	Aripiprazole (Abilify)FDA Link 01/2015
1	Antidepressive Agents (Antidepressants)IBA 01/2015
1	dihydrexidineIBA 07/2012
1	Oxidopamine (6 Hydroxydopamine)IBA 07/2012
1	2,3- dihydroxy- 6a,7,8,12b- tetrahydro- 6H- chromeno(3,4- c)isoquinolineIBA 07/2012
1	AcaricidesIBA 08/2011
1	QuinpiroleIBA 09/2006
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2004

Therapy/Procedure

2	Therapeutics 03/2024 - 03/2015
1	Spinal Injections 01/2022
1	Injections 09/2006